Fernández-Real Jose-Manuel, López-Bermejo Abel, Castro Antoni, Casamitjana Roser, Ricart Wifredo
Unit of Diabetes, Endocrinology, and Nutrition, Hospital de Girona Dr. Josep Trueta, Ctra. França s/n, 17007 Girona, Spain.
J Clin Endocrinol Metab. 2006 Sep;91(9):3337-43. doi: 10.1210/jc.2006-0841. Epub 2006 Jun 27.
Levels of TSH respond to fluctuations in serum free T(4) (fT(4)) but remain in a very narrow individual range. There exists current controversy regarding the upper limit of normal serum TSH values above which treatment should be indicated.
We aimed to study whether the individually determined fT(4)-TSH relationship was associated with plasma lipids, insulin sensitivity, and endothelial dysfunction in healthy subjects with strictly normal thyroid function according to recent recommendations (0.3-3.0 mU/liter).
This was a cross-sectional study.
The study consisted of a cohort of healthy men from the general population (n = 221).
Oral glucose tolerance, insulin sensitivity (S(I), minimal model), endothelium-dependent vasodilation (high-resolution ultrasound), and plasma lipids were measured in relation to thyroid function tests.
Both serum TSH and fT(4).TSH product were positively associated with fasting and postload insulin concentration and negatively with S(I). After body mass index stratification, these associations were especially significant among lean subjects. Serum TSH and fT(4).TSH product also correlated positively with fasting triglycerides and negatively with high-density lipoprotein cholesterol. In a multiple linear regression analysis, age (P = 0.007) and S(I) (P = 0.02) but not body mass index, fasting triglycerides, or serum high-density lipoprotein concentration contributed independently to 3.7 and 3.3%, respectively, of the variance in fT(4).TSH. Those subjects over the median of fT(4).TSH showed reduced endothelium-dependent vasodilation.
Thyroid function tests are intrinsically linked to variables of insulin resistance and endothelial function. It is possible that underlying factors lead simultaneously to increased serum TSH, insulin resistance, ensuing dyslipidemia, and altered endothelial function even within current normal TSH levels.
促甲状腺激素(TSH)水平会对血清游离甲状腺素(fT(4))的波动做出反应,但仍处于非常狭窄的个体范围内。目前对于正常血清TSH值的上限存在争议,超过该上限就应进行治疗。
我们旨在研究根据近期建议(0.3 - 3.0 mU/升)甲状腺功能严格正常的健康受试者中,个体确定的fT(4)-TSH关系是否与血浆脂质、胰岛素敏感性和内皮功能障碍相关。
这是一项横断面研究。
该研究由一组来自普通人群的健康男性组成(n = 221)。
测量口服葡萄糖耐量、胰岛素敏感性(S(I),最小模型法)、内皮依赖性血管舒张(高分辨率超声)以及与甲状腺功能测试相关的血浆脂质。
血清TSH和fT(4)·TSH乘积均与空腹及负荷后胰岛素浓度呈正相关,与S(I)呈负相关。在按体重指数分层后,这些关联在瘦受试者中尤为显著。血清TSH和fT(4)·TSH乘积也与空腹甘油三酯呈正相关,与高密度脂蛋白胆固醇呈负相关。在多元线性回归分析中,年龄(P = 0.007)和S(I)(P = 0.02)而非体重指数、空腹甘油三酯或血清高密度脂蛋白浓度分别独立地对fT(4)·TSH变异的3.7%和3.3%有贡献。fT(4)·TSH中位数以上的受试者内皮依赖性血管舒张降低。
甲状腺功能测试与胰岛素抵抗和内皮功能变量内在相关。即使在当前正常TSH水平范围内,潜在因素也可能同时导致血清TSH升高、胰岛素抵抗、继而出现血脂异常以及内皮功能改变。